Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers
Background Subthalamic deep brain stimulation (STN‐DBS) can ameliorate gait disturbances in Parkinson's disease (PD). Using motor imagery and positron emission tomography (PET), we investigated how STN‐DBS interacts with supraspinal locomotor centers in PD. Methods Ten PD patients with bilatera...
Saved in:
Published in | Movement disorders Vol. 30; no. 8; pp. 1121 - 1125 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.07.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0885-3185 1531-8257 |
DOI | 10.1002/mds.26229 |
Cover
Summary: | Background
Subthalamic deep brain stimulation (STN‐DBS) can ameliorate gait disturbances in Parkinson's disease (PD). Using motor imagery and positron emission tomography (PET), we investigated how STN‐DBS interacts with supraspinal locomotor centers in PD.
Methods
Ten PD patients with bilateral STN‐DBS actually walked or stood still under STN‐DBS ON or OFF conditions. Directly thereafter, subjects imagined walking or standing while changes in regional cerebral blood flow were measured by PET.
Results
Independent of STN‐DBS, imagined walking distance correlated with imagery duration. Compared with STN‐DBS OFF, STN‐DBS ON improved actual gait and increased imagined walking distance. Imagery of gait (vs. stance) induced activity in the supplementary motor area and the right superior parietal lobule for both STN‐DBS conditions. The improvement of imagined gait during STN‐DBS ON led to activity changes in the pedunculopontine nucleus/mesencephalic locomotor region (PPN/MLR).
Conclusions
Data suggest that STN‐DBS improves Parkinsonian gait by modulating PPN/MLR activity. © 2015 International Parkinson and Movement Disorder Society |
---|---|
Bibliography: | ark:/67375/WNG-Q5WPRW54-9 ArticleID:MDS26229 Kompetenznetz Parkinson - No. BMBF FK01GI0201 istex:7F394F86EA13C2A25E5D24E6C5469DD91797CFE8 Full financial disclosures and author roles may be found in the online version of this article. This study was supported by the Kompetenznetz Parkinson (BMBF FK01GI0201). Drs. Weiss, Herzog, Pötter‐Nerger, Falk, Herzog, and Deuschl have nothing to report. Dr. Volkmann was supported by funding from the German Ministry of Research through the Network of European Funding for Neuroscience Research (ERA‐Net Neuron) scheme (grant #01eW0902). Dr. Fink was supported by the German Research Foundation (DFG KFO 219, Fi 773/8‐1 and Schu 1439/3‐1). Shared first authorship. Shared senior authorship. Relevant conflicts of interest/financial disclosures Funding agencies ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.26229 |